Sign in

CIK 0001439222 · Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
  1. 4 Planned sale Principal Accounting Officer sold 273 shares at $25.14 ($6,863)
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. 4 Planned sale Chief Legal Officer sold 1,708 shares at $21.64 ($36,961)
  10. 4 Planned sale Chief Medical Officer sold 1,708 shares at $21.64 ($36,961)
  11. 4 Planned sale Chief Financial Officer sold 1,886 shares at $21.64 ($40,813)
  12. 4 Planned sale Director sold 10,722 shares at $21.64 ($232,024)
  13. 4 Planned sale Chief Executive Officer sold 7,635 shares at $21.64 ($165,221)
  14. 4 Planned sale Chief Commercial Officer sold 1,618 shares at $21.64 ($35,014)
  15. SC 13G/A Stake Amended Statement of Ownership
  16. 4 Planned sale Chief Executive Officer sold 12,066 shares at $22.99 ($277,397)
  17. 4 Planned sale Director sold 8,391 shares at $22.99 ($192,909)
  18. 4 Planned sale Chief Legal Officer sold 1,163 shares at $22.99 ($26,737)
  19. 4 Planned sale Chief Medical Officer sold 1,789 shares at $22.99 ($41,129)
  20. 8-K Event Regulation FD disclosure

Page 14 of 66 · 1,304 filings